NCT02958488View on ClinicalTrials.gov

Efficacy and Tolerance of High Flow Nasal Cannula for Respiratory Distress Syndrom in Late Preterms (34-36 Weeks)

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 16, 2016

Primary Completion Date

July 31, 2019

Study Completion Date

August 25, 2020

Conditions
Respiratory Distress SyndromHigh Flow Nasal Cannula
Interventions
DEVICE

High Flow Nasal Cannula

Trial Locations (1)

34295

University Hospital of Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02958488 - Efficacy and Tolerance of High Flow Nasal Cannula for Respiratory Distress Syndrom in Late Preterms (34-36 Weeks) | Biotech Hunter | Biotech Hunter